Neuraxis, Inc.

NRXS XASE • ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

87M

Short interest (May 15)

3.3%

Net Short (Jun 03 ): -0.2%

Borrow Fee

0.52%

↓ 0.8%

Available Shares

↓ 9.6%

Price Chart

Company Overview

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Company Info

Exchange: XASE

Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

CIK: 0001933567

Asset Type: CS

Market Data

Market Cap: $86,814,679

Employees: 24

Status: Active

Short Interest

Current Borrow Fee 0.52%

Range: 0.46% - 0.52%

Available Shares 1M

Range: 1.2M - 1.2M

Recent Changes

Fee Change: ↑ 2.1%

Available Change: ↑ 4.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime